Drreddys Laboratories | RDY - Trade Debtors


Drreddys Laboratories reported INR123.17B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
ANI Pharmaceuticals USD 274.47M 19.04M Jun/2026
Aurora Cannabis CAD 44.58M 3.68M Mar/2026
Bayer EUR 18.7B 146M Jun/2026
Canopy Growth CAD 36.29M 104.13M Mar/2026
Cipla INR 62.19B 12.42B Mar/2026
Corcept Therapeutics USD 76.92M 37.85M Jun/2026
Drreddys Laboratories INR 123.17B 121.76B Mar/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Lonza CHF 1.78B 55M Dec/2025
Novartis USD 9.85B 252M Jun/2026
Pacira USD 132.42M 6.78M Jun/2026
Phibro Animal Health USD 215.87M 2.02M Dec/2025
Prestige Brands USD 187.36M 4.56M Jun/2026
Richter Gedeon HUF 250.25B 5.43B Mar/2026
Sun Pharmaceuticals INR 162.09B 5.05B Mar/2026
Supernus Pharmaceuticals USD 211.66M 29.47M Jun/2026
Teva Pharmaceutical Industries USD 3.49B 100M Jun/2026